Revolutionizing personalized healthcare. Roche Italy joins us a partner at FH22
Roche Italy will be with us in Milan further fueling our partners ecosystem. Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. Roche Italy was founded in 1987 in Milan, celebrating its 125th anniversary this year. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. Roche is a pioneer in personalized healthcare and wants to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person they partner with many stakeholders and combine their strengths in Diagnostics and Pharma with data insights from the clinical practice.
Connecting the industry through medical devices and telemedicine. GIMA has arrived as a FH22 partner
GIMA, a family company in their third generation, has been a leader in manufacturing and distributing medical devices since 1926. With a range of over 9,500 medical products always available in stock, they supply a network of about 10,000 dealers of medical devices in 150 countries from their warehouse in Milan. GIMA has achieved major certifications: ISO 9001, ISO 13485, manufacturer of medical devices as well as IVD, and are upgrading to MDR.
Making digital medicine a reality in neuroscience, Biogen to collaborate at Frontiers Health 2022
We’re excited to welcome Biogen as a valuable conference partner, bringing their vast experience in the field of neuroscience, and more specifically, from their global unit dedicated to pioneering personalized and digital medicine, Biogen Digital Health. For over 40 years, Biogen has been pioneering novel science that goes deep into the human nervous system. Biogen believes that neuroscience is the next frontier, with few areas holding as much need or as much promise for medical breakthroughs as neuroscience. However, there are still significant challenges in the ways neurological disease are understood and treated. With today’s exponential technological progress, Biogen believes that now more than ever, biology and technology should come together to better meet patient needs.
Publishers, consultants and creatives bringing healthcare together. pharmaphorum is back at FH22
We are excited that pharmaphorum will cover Frontiers Health as a media partner. A leading online destination for healthcare and pharmaceutical industrynews, insight, and debate, pharmaphorum draws in its industry insider audience with daily news coverage and features, a bi-monthly digital magazine Deep Dive, and regular video and podcast interviews with movers and shakers. pharmaphorum’s mission is to cover the life sciences industry in this moment of innovation and digital transformation, and there’s no better place to do that than at FH22 where leaders in that industry will be gathered to share notes on their own digital journeys.
Orion returns at Frontiers Health 2022 to unleash the power of digital therapeutics for chronic pain
We are happy that Orion will join us again as a conference partner. Orion is a globally operating Finnish pharmaceutical company. They develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and self-care products. The core therapy areas of their pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion primarily serves healthcare service providers and professionals such as specialists and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories.
Connecting patients and clinicians wherever they are. Teladoc Health brings their transformative technology to FH22!
We’re excited to announce our renewed partnership with Teladoc Health! As a global leader in whole-person virtual care, Teladoc Health empowers everyone everywhere to live their healthiest lives by transforming the healthcare experience through technology. Teladoc Health does this by leveraging more than two decades of expertise to provide patients everywhere with unified whole-person care which includes primary care, physical and mental health and chronic condition management. Through data-driven insights, seamless care coordination and personalized care, Teladoc Health inspires and accelerates better health decisions and promotes clinical collaboration that ultimately improves the quality of care for all. Teladoc Health virtual care software and devices connect patients and clinicians wherever they are, and you can learn more at Frontiers Health this October.
Accelerating innovation for a healthier world, IQVIA renews Frontiers Health partnership
IQVIA will be back at Frontiers Health 2022 as our partner powering healthcare with intelligent connections across all aspects of the industry. The company delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology, and extensive domain expertise and uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that enables healthcare stakeholders to identify disease patterns and find the precise treatment path and therapies needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, driving the path toward cures.
Innovation beyond imagination. Chugai joins the likes of Frontiers Health partners
We are thrilled to announce that Chugai Pharma Germany GmbH will partner at Frontiers Health 2022! With a pioneering spirit, Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai is committed to creating innovative pharmaceutical products that may satisfy unmet medical needs in the strategic fields of Immunology/Rheumatology, Haematology/Haemophilia, Oncology as well as other therapeutic areas that need serious advancements to keep pace with medical demands. Chugai is listed on the Prime Market of the Tokyo Stock Exchange. While maintaining autonomy and management independence, Chugai is an important member of the Roche Group. Dedicated to adding value by creating and delivering innovative products and services for the medical community and human health around the world, they will bring their unique innovative energy to further enrich the Frontiers Health ecosystem.
Frontiers Health welcomes brilliant, passionate researchers and academics to the 2022 conference!
Over the years, Frontiers Health has been hosting global conferences and other initiatives to gather like-minded people committed to reinventing future health and care delivery. The academic community plays a central role in bringing new ideas into our ecosystem of expert thinkers and doers across a wide range of verticals. Our community of health innovators is joined by prominent academics, educators, researchers, philanthropists, scientists, and technologists. As research focused on digital health becomes more and more widely recognized as key to scaling this transformative area of medicine, Frontiers Health is looking for academic researchers and Ph.D. students interested in the conference to grant complimentary full access passes.
The AI-powered mental health ally Woebot Health partners with Frontiers Health
We’re pleased that Woebot Health will be a notable addition to our Frontiers Health ecosystem as a conference partner. Woebot Health is the world’s first mental health ally for people and businesses, with products that put personal growth in people’s hands, wherever they are. The company’s pipeline of prescription digital therapeutics and behavioral health products combine sophisticated artificial intelligence and natural language processing, decades of clinically-proven techniques and a relational agent called Woebot, which together form the foundation for mental health solutions that engage at scale and fit right into people’s lives. With beginnings as a small tech experiment alleviating anxiety in teens, Woebot Health has grown into an emerging force of change in mental health. Besides the opportunity to be supported by such a committed partner, we’re very proud to host Monique Levy, Chief Commercial & Strategy Officer at Woebot Health, as a valued member of the conference Steering Committee.
Everywhere and Anywhere around Healthcare Innovation. Jessica DaMassa returns to FH22!
Jessica DaMassa, Executive Producer & Host WTF Health will share the stage once again as Co-master of ceremony with our chairman, Roberto Ascione. In addition, WTF Health will be involved as an official media partner of the conference. Jessica’s high energy, curiosity, and ability to ask the right questions, along with her great stage presence, will contribute to creating another engaging experience for our delegates, both in-person and remotely connected. She will also be highly involved off-stage, speaking with startups and tech companies across industry verticals, and interviewing industry champions, at our FH video lounge and throughout the event. Meet our very own Jessica and chat it up with her at #FH22. Be sure to grab your spot at the conference by registering here.
Supporting innovation and expanding global access to care. StartUp Health is back to Frontiers Health!
We are pleased to renew our partnership with StartUp Health at FH22! StartUp Health is a group of impact-driven entrepreneurs and investors building a global army of thousands of Health Transformers collaborating to achieve Health Moonshots — the biggest health challenges of our time like ending cancer, curing diseases like diabetes and Alzheimer’s, and delivering quality care to everyone in the world. What a great fit for the global community health innovators consolidated by Frontiers Health over the years! Since 2011, StartUp Health have invested in more than 400 innovative health companies. StartUp Health will actively participate in the conference by showcasing some of its Health Transformers, out of its extraordinary digital health portfolio spanning 27 countries. Join StartUp Health and its contagious enthusiasm at FH22.
United towards global health innovation. Bayer G4A joins us once again at FH22!
We are excited to join forces again with Bayer G4A at this edition of Frontiers Health! Bayer G4A is the digital health partnerships and investments team at Bayer dedicated to scaling digital health companies in order to create an impact and change the experience of health. G4A works passionately toward their vision to reach health for all through digital health by collaborating with like-minded start-ups, digital health companies, government, investors, and strategic partners to offer early stage start-up investments as well as commercial partnerships and late stage investments. Since its launch in 2013, G4A (formerly Grants4Apps) has partnered with over 150 digital health companies across more than 13 countries. They will join us in Milan and online to further expand our global innovation ecosystem. If you are a trailblazing digital health company interested in funding and/or commercial partnership opportunities with Bayer, connect with G4A via firstname.lastname@example.org and discover how they are driving health equity, access and sustainability: http://www.g4a.health
Introducing the guiding themes for the Frontiers Health 2022 global conference
On the occasion of the seventh edition of our global conference, we at Frontiers Health have identified compelling Guiding Themes around which our Steering Committee has been shaping an immersive and insightful conference program. Continuing our consolidated conference trend, we’ll keep focusing on digital therapeutics and, as this space matures, we will analyze the dynamics of their adoption into clinical practice and discuss Global / EU regulatory, pricing and integration issues with a special focus on partnership strategies and practical experiences. Research strategies and clinical evidence sufficiency will also be in discussion. These Guiding Themes will be explored throughout the two-day event, both in Day 1 plenary sessions and Day 2 parallel breakout sessions.
Establishing tomorrow’s standard of care. Debiopharm returns to Frontiers Health 2022
Debiopharm develops, manufactures and invests in innovative therapies and technologies that respond to high unmet medical needs in oncology and bacterial infections. Debiopharm Innovation Fund aims to provide strategic funding and guidance for companies with Smart Data & Digital Health solutions with the ambition to change the way drugs are developed and the way patients are treated. Their growing portfolio of company achievements include 18 FDA clearances or CE marks and 2 IPOs along with 3 successful exits from mergers & acquisitions. Since 2018 Debiopharm has invested over USD 150 million, leading 22 of the past 30 investment rounds.
Transformative places collide as Frontiers Health returns to Milan at a new location, Palazzo del Ghiaccio, for its 2022 Edition
In line with Frontiers theme of transformation, we will hold our FH22 in the Palazzo del Ghiaccio in Milan. Dating back to 1899 with origins as an ice-skating rink with connected refrigerated warehouses, it has been reimagined into a beautiful liberty style building and hub for the most fascinating events in Milan as a true driver of Art and Culture for the city and beyond. Returning for another hybrid format, we are pleased to operate within the walls of the Palazzo as its connected architectural structure will support our interconnected ecosystem, both in our plenary sessions, breakout sessions and ongoing networking events. Connected to the Palazzo and sharing much of the building’s history and functionality, Frigoriferi Milanesi, once the ice factory of the city, will also be used to amplify the conference space and offerings. Register here and come explore Milan together or join us online October 20-21st!
Committed to building future health. Apply to our Start-up Discovery!
We are excited to announce that applications are now open to our iconic Start-up Discovery session. Over our past six global editions, we at Frontiers Health have been striving to help put emerging and established startups on the map with their proven and scalable solutions. As we have proudly witnessed, startups represent a key catalyzer to build the foundations of a new healthcare experience and can deliver an even more profound impact when collaborating with top global players in health and care. We’re humbled to have supported thousands of new healthcare ventures over the course of our journey as an ecosystem, shedding light on their promising solutions, connecting them with investors and key stakeholders, and nurturing their ingenuity with insightful know-how. To fuel the multifaceted and complex health innovation scenario again this year, we are inviting start-ups on any continent to apply with products already launched in the market and that have some initial traction, preferably in the process of raising their Series A or B funding rounds.
Deploying and scaling validated digital health solutions. Wellthy and Frontiers Health to enhance their partnership at FH22
Wellthy’s mission is to advance health equity and access to digital care in all parts of the world. The company deliver patient-companion solutions that leverage behavioral science mechanisms to deliver clinical and business outcomes at scale. Wellthy enable our partners to build and own next-generation digital solutions (DTx 2.0) through a single, commercially and clinically validated front-end, on a regulatory compliant back-end
Aptar Digital Health at FH22. Augmenting treatment experiences with integrated digital solutions
Aptar Digital Health is the go-to digital health expert for pharmaceutical companies that want to deliver differentiating treatment experiences to patients around the world. As an expert partner of the pharmaceutical industry, Aptar Digital Health leverages their unmatched experience and robust platforms and processes to derisk and accelerate digital health initiatives across multiple therapeutic areas. Aptar Digital Health supports pharma companies throughout their product journey to make it easier and faster to leverage the best of digital innovations to help deliver differentiating experiences, improved patient outcomes and better care.
Our team of health innovation leaders returns to the FH22 Steering Committee
We couldn’t be happier that all members of our outstanding Steering Committee will return at this year’s Frontiers Health Conference. The committee assembles Eugene Borukhovich, Chairman and COO at YourCoach.Health; Megan Coder, Vice President of Global Policy at Digital Therapeutics Alliance; Fredrik Debong, Cofounder and CPO at hi.health; Tony Estrella, Managing Director at Taliossa; Monique Levy, Chief Commercial Officer at Woebot Health; Min-Sung Sean Kim, Managing Partner at Digital Health Ventures (DHV); Marc Sluijs, Managing Partner at digitalhealth.network; and Paul Tunnah, Chief Content Officer and Managing Director UK at Healthware Group. In addition, CEO and Founder of Healthware Group Roberto Ascione will return for his seventh consecutive year leading the Steering Committee as conference chair.
Creating an impact that matters. ZS returns as a partner at this year’s conference
ZS is a professional services firm with more than 35 years of experience and 13,000-plus ZSers in more than 25 offices worldwide. Our Digital Connected Health Team helps healthcare companies including Pharmaceutical, MedTech and HealthTech develop and deliver digital medicine solutions to customers. ZS provides end-to-end collaboration from shaping digital medicine strategy (where to play, how to win) through defining the evidence generation requirements for commercial success, decentralized execution of clinical trials, and advancement of traditional portfolios through digital therapeutics and software as medical devices. ZS is passionately committed to helping companies and their customers thrive. To learn more, visit http://www.zs.com or follow them on Twitter and LinkedIn. Join us for another year at Frontiers Health, where Richard Secker-Johnson, connected health team’s associate principal, will moderate a panel with other industry leaders who will discuss how they are approaching the opportunity and challenges in digital medicine.
Creating a healthier tomorrow. Pfizer returns to Frontier Health with its Digital Innovation Lab
We are very pleased to partner with Pfizer’s Digital Innovation Lab again this year for Frontiers Health 2022, which will take place both in Milan and virtually October, 20-21. At Pfizer, more than 10,000 researchers worldwide and more than 90,000 employees total work to develop, produce, and distribute innovative drugs and vaccines that extend and improve the lives of patients. Pfizer’s Digital Innovation Lab connects with a global ecosystem of startups, innovators, and entrepreneurs to discover and co-develop digital health solutions with the potential to expand drug discovery capabilities, accelerate product development, and improve patient outcomes. More information about Pfizer’s Digital Innovation Lab can be found on their Breakthrough Change Accelerator: http://www.breakthroughchangeaccelerator.com
A new, original and better health and care experience. Transcarent is back this year at Frontiers Health
We are thrilled to welcome back Transcarent as one of partners at our 2022 conference. A consumer-focused solution, Transcarent is a health and care experience company that makes it easy to get the high-quality, affordable health and care that everyone deserves – where and when they want it, on their terms. Transcarent puts consumers back in charge by directly connecting them with an integrated ecosystem of high-value providers and health solutions, transparent information, and trusted guidance – in as little as 60 seconds, 24/7/365, from the palm of their hand, often at no cost to Members and at a lower cost to their employer. Transcarent takes accountability for results – offering at-risk pricing models and transparent impact reporting to align incentives towards measurably better experience, better health, and lower costs.
Built on science, rooted in behavioral economics and scalable across multiple therapeutic areas. A warm welcome to Sidekick at FH22
Sidekick is a digital therapeutics innovator, founded by two passionate medical doctors on a mission to improve the health of humanity. The company is driven by a vision to bring healthcare into people’s everyday lives, empowering them to take control of their own health. Sidekick’s therapeutics are developed and delivered with digital technology, addressing the same endpoints as traditional treatments – such as small molecule drugs and biologics, but with the added benefit of giving people the opportunity to be actively involved in their own treatment. When combined with traditional treatments, the overall efficacy can be strongly increased. That is why Sidekick partners with the world’s most innovative companies across the healthcare spectrum. Sidekick has offices in Berlin, Boston, Reykjavik and Stockholm.
Breaking through mental health barriers with innovative research, Compass Pathways joins us as a 2022 partner!
A warm welcome to COMPASS at this year’s Frontiers Health conference. COMPASS Pathways, a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. COMPASS is pioneering the development of a new model of psilocybin therapy, in which proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK, for treatment-resistant depression (TRD). COMPASS is headquartered in London, UK, with offices in New York and San Francisco in the US. Their vision is a world of mental wellbeing. http://www.compasspathways.com
A consolidated partnership to explore the future of health. Healthware Group to co-host Frontiers Health Global Hybrid Conference 2022
Healthware Group enhances its commitment as a global player in the health innovation space by renewing the foundational alliance with Frontiers Health, for its seventh edition, taking place in person in the ingenious and resourceful city of Milan, Italy, and virtually on October 20-21, 2022. As conference global co-host and main sponsor, working at the intersection of technology, life sciences, and communications, Healthware Group has been tapping into its truly transformational attitude and global reach to leverage Frontiers Health among one of the leading global health innovation events, shaping an evolving, committed, responsible and forward-looking ecosystem, that performs and delivers well beyond their periodic global gatherings. This year’s conference will explore guiding themes inspired by the most compelling topics, including digital therapeutics & medicine, digital care delivery, telehealth, digital transformation, cross-industry innovations, funding & scaling, health equity and access.
After a successful 2021 global edition in such a vibrant and forward-looking city, we’re excited to announce that Frontiers Health returns in October in Milan, Italy, both in-person and virtually. Our global events held in 2020 (Fight the Pandemic and FH20) and 2021 demonstrated the importance of developing guidance for stakeholders on how best to deploy digital health and data and support public health in an integrated manner to overcome the COVID-19 pandemic and future health challenges. So now more than ever you’ll want to be at the epicenter of the digital health ecosystem, where we bring together international thought leaders, policymakers, key industry players, and companies for a two-day deep dive into the ongoing threats, strategic trends, and scalable solutions for: on one side, the rapid preparedness and optimal global responses; on the other side, enabling the healthcare systems to perform as more inclusive and accessible in terms of better patient experience and cost. There are a limited number of in-person and digital passes available at our Super Early Bird pricing, so purchase yours today to reserve your spot at the premier global digital health innovation event of the year!